News

NVIDIA Outlook Optimistic as Analysts Predict Robust Growth

NVIDIA Outlook Optimistic as Analysts Predict Robust Growth

NVIDIA’s Potential Growth Sparked by H20 GPU Approval

BofA Securities analyst Vivek Arya recently reiterated a Buy rating for NVIDIA Corp (NASDAQ: NVDA), setting a price target of $220. This bullish outlook comes ahead of NVIDIA's anticipated second-quarter earnings, underscored by sustained momentum in sales and solid long-term earnings projections.

Anticipated Revenue Surge for NVIDIA

Arya's forecast indicates that NVIDIA could generate second-quarter revenues around $47 billion, surpassing both the $45.8 billion consensus and NVIDIA's self-imposed $45 billion guidance. This revenue growth is attributed to strong performance in Blackwell GPUs and substantial investments in cloud infrastructure.

10% Potential Revenue Increase in Q3

For the third quarter, Arya predicts mid-teens sequential growth to approximately $54 billion, which also exceeds the consensus estimate of $52.5 billion. There’s further upside potential to $57–$60 billion if shipments for the H20 GPUs are allowed to recommence.

Rising Gross Margins and Long-Term Predictions

Gross margins are expected to elevate to 73%–74% by the third quarter, propelled by NVIDIA's robust rack-scale architecture. If the previously written-down H20 inventory valued at approximately $5.5 billion is utilized, margins could see a boost of 200–300 basis points. Arya has also adjusted sales forecasts for fiscal year 2026 (calendar 2025) to a range of $210–$215 billion, with anticipated pro forma EPS climbing to $4.70–$4.80, which is above the consensus of $4.38.

Impact of AI Investments on NVIDIA’s Performance

Arya's projections reflect consistent strength in NVIDIA’s Blackwell and Blackwell Ultra series, stemming from increasing AI-related capital expenditures by key hyperscalers like Alphabet's Google, Meta Platforms, Oracle, and xAI. This diversified clientele hints at a solid upcoming product pipeline, which should enhance profitability while opening doors for potential sales of $5–$10 billion from resumed H20 sales in the latter half of the year.

Challenges Ahead: Regulatory Risks and Competition

While optimism persists around NVIDIA's growth, Arya cautions about potential regulatory challenges affecting H20 shipments due to anticipated security probes in China. Additionally, as local contenders advance, the competitive landscape could shift, necessitating strict adherence to U.S. licensing regarding the shipment of 1-nm or 2-nm chips to maintain NVIDIA's competitive edge over rivals like Advanced Micro Devices.

Investment Trends Supporting Long-Term Growth

Recent robust capital expenditure forecasts from major U.S. hyperscalers bolster Arya's positive long-term perspective. For example, Meta has elevated its projected spend to $100 billion by calendar 2026, up from a previous estimate of $79 billion, signifying increased investment in server technologies. Financing these expansions, Microsoft noted that their spending is directly linked to secured contracts, aligning with overall trends benefiting NVIDIA.

Profit Projections Aligning with Market Growth

Reflecting on these market dynamics, Arya anticipates fiscal year 2027 (calendar 2026) earnings could hover around $7 per share, comparing favorably with a consensus of $5.87. Such growth assumes the total addressable market for AI accelerators expands significantly, projected to increase from $309 billion to $341 billion, proceeding at a 60% year-over-year growth rate. Consequently, NVIDIA could trade at 25 times forward earnings, consistent with its traditional P/E range.

Long-Term EPS Growth Potential

Looking further ahead, Arya suggests NVIDIA could target long-term EPS of $10 per share. He estimates that the company could capture about 10% of the global AI accelerator TAM, citing that NVIDIA has placed additional orders for 300,000 H20 GPU units with Taiwan Semiconductor Manufacturing Co (NYSE: TSM), along with previous orders of 600,000–700,000 units. If U.S. regulators approve these shipments, potential incremental sales from China could range from $6 to $10 billion, translating to an average selling price of around $10,000 per unit.

Investor Outlook on NVIDIA Performance

Despite the rosy expectations, Arya highlighted that some revenue might shift into the next year, with projections of $3–$4 billion potentially delayed due to supply chain ramp-up times. There are ongoing discussions among investors regarding the potential balance between H20 products, particularly concerning the yield challenges associated with standard Blackwell versus Blackwell Ultra series.

NVIDIA Stock Performance Snapshot

At the time of publication, NVIDIA shares have risen by 2.49%, trading at $178.05. This encourages optimism around NVIDIA's near-term outlook as it enters a phase of potential demand expansion driven by technological advancements and strategic market positioning.

Frequently Asked Questions

What is NVIDIA's current stock price?

NVIDIA's stock is trading at $178.05, showing a gain of 2.49% at the time of reporting.

What factors are influencing NVIDIA's revenue growth?

Strong sales of Blackwell GPUs and increasing demand from cloud infrastructure investments are key factors driving NVIDIA's revenue growth.

How do analysts predict NVIDIA's EPS growth?

Analysts project NVIDIA's earnings per share could approach $7 in fiscal 2027, with long-term targets around $10 per share.

What risks does NVIDIA face regarding the H20 GPU shipments?

NVIDIA could encounter regulatory risks connected to security checks in China, impacting H20 GPU sales and market competitiveness.

How are AI capital expenditures affecting NVIDIA's outlook?

Increased AI-related spending by major companies is enhancing NVIDIA's product pipeline and sales potential, particularly among hyperscalers.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading

Top 5 Most Recently Viewed Articles

Aberdeen Global Income Fund Announces Shareholder Meeting Date

Updated Category News Views 74

Aberdeen Global Income Fund Plans Significant Shareholder Meeting Aberdeen Global Income Fund, Inc. (NYSE American: FCO) has taken an important step as it sets the record date for its upcoming shareholder meeting. The meeting is crucial as it will address a proposed merger into Aberdeen Asia-Pacific Income Fund, Inc. (NYSE American: FAX). Shareholders of FCO who are on...

Continue Reading
BellRing Brands To Discuss Q1 2025 Financial Results Soon

Updated Category News Views 142

BellRing Brands Announces Upcoming Conference Call BellRing Brands, Inc. has confirmed a significant event for stakeholders interested in its performance. The company is gearing up for an important conference call to delve into its financial results for the first quarter of fiscal year 2025 and discuss future expectations. Details of the Conference Call The call is slated...

Continue Reading
Bitfarms Investors Alerted About Upcoming Class Action Lawsuit

Updated Category News Views 165

Overview of the Class Action Lawsuit Against Bitfarms Ltd. Bitfarms Ltd. is currently facing a class action lawsuit that has garnered the attention of many investors. Levi & Korsinsky, LLP serves as a key notifier for individuals who may have been adversely affected due to this legal action. The class action aims to represent a collective group of investors in a bid to...

Continue Reading
Intellinum's Latest FlexiPro Disconnect Revolutionizes Operations

Updated Category News Views 419

Intellinum Introduces FlexiPro Disconnect for Seamless Operations Intellinum, a leader in enterprise mobility and digital transformation solutions, is thrilled to introduce FlexiPro Disconnect. This innovative tool is designed specifically for organizations using Oracle Cloud, enabling them to maintain uninterrupted operations during essential maintenance windows....

Continue Reading
Family Pursues Justice in Andrea Vazquez Murder Case

Updated Category News Views 397

Family Pursues Justice in Andrea Vazquez Murder Case The tragic murder of Andrea Vazquez has deeply affected her family, who now tirelessly seek justice amidst the heart-wrenching circumstances surrounding her abduction and death. The situation is particularly poignant as the suspect, Gabriel Sean Esparza, is believed to have had no prior connection to Vazquez, making...

Continue Reading